gemcitabine has been researched along with Rhabdoid Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fujisaki, H; Hara, J; Hira, K; Ishii, Y; Matsubara, K; Nitani, C; Okada, K; Okuhiro, Y; Tanimura, K; Yamasaki, K | 1 |
1 other study(ies) available for gemcitabine and Rhabdoid Tumor
Article | Year |
---|---|
[Gemcitabine and Docetaxel for the Treatment of Relapsed and Refractory Malignant Rhabdoid Tumor of Kidney and Atypical Teratoid Rhabdoid Tumor].
Topics: Deoxycytidine; Docetaxel; Gemcitabine; Humans; Kidney; Rhabdoid Tumor; SMARCB1 Protein; Teratoma | 2021 |